Cyclosporine induces the expression of the cyclin inhibitor p21.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Transplantation

• Publication date

  1999-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-199905150-00011PMID 10342319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression.

  1999cited by this paper
• Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine.

  1999cited by this paper
• Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.

  1999cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction

  1998cited by this paper
• Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells.

  1998cited by this paper
• Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression

  1998cited by this paper
• Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression

  1998cited by this paper
• Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.

  1998cited by this paper
• TGF-beta: a link between immunosuppression, nephrotoxicity, and CsA.

  1998cited by this paper
• TGF-β: A Link Between Immunosuppression, Nephrotoxicity, and CsA

  1998cited by this paper
• Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1.

  1997cited by this paper
• Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation.

  1997cited by this paper
• Regulation of CDK/cyclin complexes during the cell cycle.

  1997cited by this paper
• Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.

  1997cited by this paper
• Clinical application of molecular biology: a study of allograft rejection with polymerase chain reaction.

  1997cited by this paper
• In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine.

  1997cited by this paper
• Regulation of Cell Cycle-Related Genes in Rat Hepatocytes by Transforming Growth Factor β1

  1997cited by this paper
• Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression.

  1996cited by this paper
• Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control.

  1996cited by this paper
• Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.

  1996cited by this paper
• Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

  1996cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney.

  1995cited by this paper
• Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes.

  1995cited by this paper
• Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (*)

  1995cited by this paper
• CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS

  1995cited by this paper
• Mechanism of action of cyclosporine: a new hypothesis implicating transforming growth factor-β

  1995cited by this paper
• Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle

  1995cited by this paper
• Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

  1995cited by this paper
• Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*)

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells.

  1994cited by this paper
• Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

  1994cited by this paper
• Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA.

  1994cited by this paper
• Cdk inhibitors: on the threshold of checkpoints and development.

  1994cited by this paper
• Regulation of Transforming Growth Factor-β1 (TGF-β1) Expression with a Novel TGF-β1 Complementary DNA

  1994cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

  1994cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

  1994cited by this paper
• Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.

  1994cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

  1993cited by this paper
• Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.

  1993cited by this paper
• Rapamycin Inhibits p34cdc2 Expression and Arrests T Lymphocyte Proliferation at the G1/S Transition

  1993cited by this paper
• Regulation of transcription by the retinoblastoma protein

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

  1992cited by this paper
• Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• Differential regulation of the expression of transforming growth factor‐βs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK‐49F and A549 cells

  1991cited by this paper
• Effects of cyclosporin on C57BL/6 splenocytes before and after culture with high-dose recombinant interleukin-2: Implications for immunosuppression with cyclosporin

  1990cited by this paper
• Cyclin mRNA and protein expression in recombinant interleukin 2‐stimulated cloned murine T lymphocytes

  1988cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper
• Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

  1984cited by this paper
• Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

  1982cited by this paper
• The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

  1982cited by this paper

• Calcineurin in cancer signaling networks

  2025cites this paper
• The Impact of Calcium Depletion on Proliferation of Chlorella sorokiniana Strain DSCG150

  2024cites this paper
• Förster Resonance Energy Transfer-Based Single-Cell Imaging Reveals Piezo1-Induced Ca2+ Flux Mediates Membrane Ruffling and Cell Survival

  2022cites this paper
• Distinct roles of ORAI1 in T cell–mediated allergic airway inflammation and immunity to influenza A virus infection

  2022cites this paper
• Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin

  2022cites this paper
• 5 Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein : A Potential Contributor to the Development of Hepatocellular Carcinoma

  2018cites this paper
• Rôle de la signalisation calcique dans la leucémie myéloïde chronique

  2016cites this paper
• Porphyromonas gingivalis promotes the cell cycle and inflammatory cytokine production in periodontal ligament fibroblasts.

  2015cites this paper
• Modulation of Cell Proliferation Pathways by the Hepatitis B Virus X Protein: A Potential Contributor to the Development of Hepatocellular Carcinoma

  2012cites this paper
• Cyclosporine A enhances apoptosis in gingival keratinocytes of rats and in OECM1 cells via the mitochondrial pathway.

  2009cites this paper
• Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis

  2009cites this paper
• Cyclin kinase inhibitor p21: a mediator of immune tolerance: direct and indirect evidence

  2009cites this paper
• Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.

  2008cites this paper
• Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival

  2008cites this paper
• Transforming growth factor-β: From its effect in T cell activation to a role in dominant tolerance

  2008cites this paper
• The Immune Synapse as a Novel Target for Therapy

  2008cites this paper
• Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.

  2008cites this paper
• Expression of p21 and p53 in rat gingival and human oral epithelial cells after cyclosporine A treatment.

  2007cites this paper
• Targeted in vitro and in vivo gene transfer into T Lymphocytes: potential of direct inhibition of allo-immune activation

  2006cites this paper
• Recombinant p21 Protein Inhibits Lymphocyte Proliferation and Transcription Factors

  2005cites this paper
• Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation

  2005cites this paper
• Factors Lymphocyte Proliferation and Transcription Recombinant p 21 Protein Inhibits and

  2005cites this paper
• The role of ceramide in growth arrest and terminal differentiation of human leukaemia cells

  2004cites this paper
• Pharmacology of calcineurin antagonists.

  2004cites this paper
• Concerted effect of transforming growth factor-beta, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation.

  2004cites this paper
• Calcineurin regulates cyclin D1 accumulation in growth-stimulated fibroblasts.

  2004cites this paper
• Immunosuppression and transplant vascular disease: benefits and adverse effects.

  2003cites this paper
• Regulation of cell cycle progression by calcium/calmodulin-dependent pathways.

  2003cites this paper
• Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes.

  2003cites this paper
• The immunosuppressive agent tacrolimus induces p21WAF/CIP1WAF1/CIP1 via TGF-beta secretion.

  2003cites this paper
• Cyclosporin and tacrolimus do not potentiate oxidative damage in pulmonary epithelial cells

  2003cites this paper
• Prolongation of Skin Xenograft Survival with Modified Cultured Fibroblasts; Selçuk Işik, M.D., Ergin Er, M.D., Yasemin Soysal, M.S., and Nejat İmırzalioğlu, M.D.

  2003cites this paper
• Increased expression of p21 (WAF1/CIP1) cyclin‐dependent kinase (CDK) inhibitor gene in chronic allograft nephropathy correlates with the number of acute rejection episodes

  2003cites this paper
• Increased expression of p21 (WAF1/CIP1) cyclin-dependent kinase (CDK) inhibitor gene in chronic allograft nephropathy correlates with the number of acute rejection episodes

  2003cites this paper
• Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control.

  2002cites this paper
• Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus.

  2002cites this paper
• Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy

  2002cites this paper
• Relative Quantification of mRNA Levels in Jurkat T Cells with RT-Real Time-PCR (RT-rt-PCR): New Possibilities for the Screening of Anti-Inflammatory and Cytotoxic Compounds

  2002cites this paper
• Cyclosporine Inhibits Growth through the Activating Transcription Factor/cAMP-responsive Element-binding Protein Binding Site in the Cyclin D1 Promoter*

  2002cites this paper
• The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.

  2001cites this paper
• Cell cycle control and immunosuppression in organ transplantation.

  2001cites this paper
• The role of transforming growth factor-beta in the modulation of mouse cranial suture fusion.

  2001cites this paper
• Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes.

  2001cites this paper
• This information is current as Activation Phenotype Differentiate into CTL Retaining an Early T Cells to + Memory But Not Naive CD 8 Human Vascular Endothelial Cells Stimulate

  2000cites this paper
• Cell-cycle regulation in immunity, tolerance and autoimmunity.

  2000cites this paper
• Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype1

  2000cites this paper
• Transgenic Rats Harboring Human Renin and Angiotensinogen Genes Induced End-Organ Damage in Double − Cyclosporin

  2000cites this paper
• Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models

  2000cites this paper
• In Vitro and In Vivo Transfection of p21 Gene Enhances Cyclosporin A-Mediated Inhibition of Lymphocyte Proliferation

  2000cites this paper
• Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.

  2000cites this paper
• Inhibition of Lymphocyte Proliferation Gene Enhances Cyclosporin A-mediated in Vitro and in Vivo Transfection of P21

  year unknowncites this paper